Human immunoglobulin (pH4, Sichuan Yuanda Shuyang Pharmaceutical)

人免疫球蛋白（pH4，四川远大蜀阳）

Report date: 2024/07/01 11:31:44

Base Information

Drug NameHuman immunoglobulin (pH4, Sichuan Yuanda Shuyang Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUrticariaDermatitis, Allergic ContactPurpura, Thrombocytopenic, Idiopathic +[4] 
Global Approved IndicationsUrticariaDermatitis, Allergic ContactAsthma
Approved Indications in ChinaUrticariaDermatitis, Allergic ContactAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsUrticariaDermatitis, Allergic ContactPurpura, Thrombocytopenic, Idiopathic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksDrugBank